首页> 美国卫生研究院文献>Stem Cells International >Generation of Human-Induced Pluripotent Stem Cells by a Nonintegrating RNA Sendai Virus Vector in Feeder-Free or Xeno-Free Conditions
【2h】

Generation of Human-Induced Pluripotent Stem Cells by a Nonintegrating RNA Sendai Virus Vector in Feeder-Free or Xeno-Free Conditions

机译:在无饲养者或无异种条件下通过非整合RNA仙台病毒载体生成人诱导的多能干细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The generation of induced pluripotent stem cells (iPSCs) from somatic cells has enabled the possibility of providing unprecedented access to patient-specific iPSC cells for drug screening, disease modeling, and cell therapy applications. However, a major obstacle to the use of iPSC for therapeutic applications is the potential of genomic modifications caused by insertion of viral transgenes in the cellular genome. A second concern is that reprogramming often requires the use of animal feeder layers and reagents that contain animal origin products, which hinder the generation of clinical-grade iPSCs. Here, we report the generation of iPSCs by an RNA Sendai virus vector that does not integrate into the cells genome, providing transgene-free iPSC line. In addition, reprogramming can be performed in feeder-free condition with StemPro hESC SFM medium and in xeno-free (XF) conditions. Generation of an integrant-free iPSCs generated in xeno-free media should facilitate the safe downstream applications of iPSC-based cell therapies.
机译:从体细胞中产生诱导性多能干细胞(iPSC),使得有可能为药物筛选,疾病建模和细胞治疗应用提供对患者特异性iPSC细胞的空前访问。然而,将iPSC用于治疗应用的主要障碍是由病毒转基因插入细胞基因组引起的基因组修饰的潜力。第二个问题是重新编程通常需要使用动物饲养层和包含动物源产品的试剂,这会阻碍临床级iPSC的产生。在这里,我们报告了由不整合到细胞基因组中的RNA仙台病毒载体产生的iPSC,提供了无转基因的iPSC品系。此外,可以使用StemPro hESC SFM培养基在无进料器的条件下和在无异种(XF)的条件下进行重新编程。在无异种培养基中产生的无积分iPSC应当促进基于iPSC的细胞疗法在下游的安全应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号